Asarfi Hospital reported audited FY26 standalone revenue of ₹173.20 crore, up 42% YoY, with PAT of ₹17.08 crore and 10% margin.
Operational growth driven by 46% IPD and 34% OPD revenue increases, with ARPOB reaching ₹23,020 (Super-Specialty) and ₹37,428 (Cancer Unit).
Performance led by high-acuity specialties including Cardiology, Neurosciences, Orthopaedics, and Radiation Oncology across two hospital units.
Results approved by board on May 11, 2026, and published in The Times of India and Dainik Jagran on May 12, 2026.